Lite StrategyLITS +9.89%22 Market Cap is $30.56 Mil as of Jun. 27, 2026. GuruFocus rates LITS with a GF Score™ of 22/100. The stock has 2 warning signs investors should review. Among 1,431 Biotechnology companies, Lite Strategy ranks worse than 72.26% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Lite Strategy's share price for the quarter that ended in Mar. 2026 was $1.16. Lite Strategy's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 35.16 Mil. Therefore, Lite Strategy's market cap for the quarter that ended in Mar. 2026 was $40.78 Mil.
Lite Strategy's quarterly market cap
declined
from Sep. 2025 ($86.29 Mil) to Dec. 2025 ($48.56 Mil) and
declined
from Dec. 2025 ($48.56 Mil) to Mar. 2026 ($40.78 Mil).
Lite Strategy's annual market cap
declined
from Jun. 2023 ($43.84 Mil) to Jun. 2024 ($19.39 Mil) and
declined
from Jun. 2024 ($19.39 Mil) to Jun. 2025 ($16.46 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Lite Strategy's Enterprise Value for Today is $-7.79 Mil.
Lite Strategy (NAS:LITS) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Lite Strategy Market Cap Related Terms
Lite Strategy Market Cap Historical Data
* Premium members only.
The historical data trend for Lite Strategy's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Lite Strategy's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lite Strategy Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Lite Strategy's Market Cap distribution charts can be found below:
* The bar in red indicates where Lite Strategy's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Lite Strategy's Market Cap for the fiscal year that ended in Jun. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lite Strategy (LITS) has a Market Cap of $30.56 Mil as of Jun. 27, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Lite Strategy and its competitors. According to the industry distribution chart, Lite Strategy ranks #1034 out of 1431 companies in the Biotechnology industry, placing it in the top 72.3%.
Is Lite Strategy's Market Cap too high?
Lite Strategy's current Market Cap is $30.56 Mil. The Biotechnology industry median Market Cap is 113.83. Lite Strategy's value of $30.56 Mil is 73.2% below this industry median. Based on the distribution chart, Lite Strategy ranks #1034 out of 1431 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Lite Strategy has a GF Score™ of 22/100, reflecting its overall financial health beyond just this single metric.
How does Lite Strategy's Market Cap compare to DARE and ALGS?
According to the Biotechnology industry distribution chart, Lite Strategy ranks #1034 out of 1431 companies for Market Cap. This places Lite Strategy in the lower half of its industry. The industry median Market Cap is 113.83. Lite Strategy's value of $30.56 Mil is 73.2% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 113.83, based on 1,431 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lite Strategy's current Market Cap of $30.56 Mil is 73.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Lite Strategy and its competitors. For the Biotechnology industry, the median Market Cap is 113.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lite Strategy's current Market Cap is $30.56 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lite Strategy stock overvalued right now?
Lite Strategy (LITS) has a current Market Cap of $30.56 Mil. The current Market Cap is $30.56 Mil and 73.2% below the Biotechnology industry median of 113.83. Lite Strategy's overall GF Score™ is 22/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Lite Strategy (LITS), the current Market Cap is $30.56 Mil as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
22GF Score
Get the complete analysis for LITS
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LITS has been successfully added to your 
